Loading...
Treatment with Ipilimumab: A Case Report of Complete Response in a Metastatic Malignant Melanoma Patient
INTRODUCTION: Over the past year, 3 agents have been approved for the treatment of melanoma by the Food and Drug Administration. These include pegylated interferon α-2b for stage III melanoma, vemurafenib for unresectable or metastatic melanoma with BRAF V600E mutation, and ipilimumab for unresectab...
Na minha lista:
| Main Authors: | , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
S. Karger AG
2013
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3725017/ https://ncbi.nlm.nih.gov/pubmed/23898270 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000351834 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|